Development of Novel Ex Vivo Examination Kit To Detect HER2 Protein Overexpression in Gastric Cancer
Not Applicable
Recruiting
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000031515
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with high risk of bleeding after endoscopic biopsy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Concordance rate of the examination results of HER2 overexpression obtained by our novel kit and current procedure (immunohistochemistry and in situ hybridization) using endoscopic biopsy specimens of gastric cancer,
- Secondary Outcome Measures
Name Time Method